MDCalc is launching a quality-rating system for the more than 800 clinical calculators used to assess disease risk, ...

Eli Lilly is buying the psychedelics-focused biotech AtaiBeckley for $2.8 billion upfront, a move that will expand its ...

A brain-computer interface helped restore movement and sensation in a 48-year old man with quadriplegia, researchers say.

Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health ...

Kalshi, one of the world’s largest prediction market exchanges, plans to take bets on clinical trials and regulatory ...

John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — A Senate vote to halt ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer. Send tips on Signal at LizC.22. Turmoil at the American ...

Prediction markets have permeated the worlds of sports, politics, and reality television shows. Now, the biopharma industry ...

Managing risk factors is the key to further progress in reducing deaths from coronary artery disease, a new study finds.

A former FDA toxicologist has accused the agency of authorizing Zyn nicotine pouches without fully reviewing their safety ...

CMS wants to build a standardized payment structure for clinical software and AI that factors in their impact on patient ...